Skip to content

Clinical trials

Central Nervous System Diseases trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Central Nervous System Diseases Country / region: France Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20091
20101
20111
20131
20141
20151
20162
20172
20183
20191
20205
20215
20225
20238
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Recruiting10
Terminated9
Active, not recruiting3
Not yet recruiting2
Enrolling by invitation1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
Assistance Publique - Hôpitaux de Paris3
AstraZeneca3
Centre Hospitalier Universitaire de Nice2
MapLight Therapeutics2
Novartis2
REGEnLIFE SAS2
Alkahest, Inc.1
Amzell1
AskBio France, SAS, a subsidiary of AskBio Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Central Nervous System Diseases44
Brain Diseases27
Nervous System Diseases27
Neurodegenerative Diseases16
Alzheimer Disease12
Dementia10
Mental Disorders10
Neurocognitive Disorders9
Tauopathies8
Movement Disorders7

Trials

Showing 51 to 44 of 44. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.